Angie Fagerlin, Ph.D
Tamoxifen to Prevent Breast Cancer
The drug tamoxifen can be a powerful tool in preventing breast cancer in women at high risk -- but at the expense of side effects such as hot flashes. A new study finds that even when women understand tamoxifen's benefits, only 6 percent are interested in taking it.
Dr Fagerlin comes on the show to discuss these findings and explain the results of the research. “For any given woman, there is not a right or wrong answer in regards to whether she should take tamoxifen to prevent a first diagnosis of breast cancer. The goal of decision aids is to explain the risks and benefits in a clear way so that the woman is able to weigh these factors and make an informed decision about what is best for her,” Fagerlin says.
Angie Fagerlin, Ph.D., is an associate professor of internal medicine at the University of Michigan Medical School. Dr. Fagerlin studied psychology and literature at Hope College and received her doctorate in experimental (cognitive) psychology at Kent State University. Her primary research focus is testing methods for communicating the risks and benefits of treatment to patients using decision aids. Her other research interests include studying cognitive biases involved in medical decision making and the use of living wills at the end of life.
Dr.Fagerlin is also a researcher at the University of Michigan Comprehensive Cancer Center and the VA Ann Arbor Healthcare System. She is a member of the Center for Behavioral and Decision Sciences in Medicine at the University of Michigan.?
Melanie Cole, M.S.
Get our FREE Health Newsletter!